Patent ID: 11884647
Assignee: ATENGEN, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 26:
27. The compound of claim 1, wherein the compound is of Formula (V):, or a pharmaceutically acceptable salt, isotopically enriched analog, stereoisomer, mixture of stereoisomers, or tautomer thereof,
wherein
each of s, t, u, and v is independently 0, 1, 2, or 3, provided that the sum of s and t is 1, 2, 3 or 4, and the sum of u and v is 1, 2, 3 or 4;
w is 0, 1, 2, or 3;
Z1 is C or N,
when Z1 is C, R20a is selected from H, halo, oxo, —NH2, —OH, —CN, —NO2, —NHR28, —N(R28)2, —C(O)R28, —C(O)OR28, —C(O)OH, —OC(O)R28, —S(O)0-2R28, —NHS(O)0-2R28, —S(O)0-2NHR28, —NHS(O)0-2NHR28, —C(O)NH2, —C(O)NHR28, —C(O)N(R28)2, —NHC(O)R28, —OC(O)NHR28, —NHC(O)OR28, —OC(O)N(R28)2, —NR32C(O)NH2, —NR32C(O)NHR28, —NR32C(O)N(R28)2, poly(ethylene glycol), methoxypoly(ethylene glycol), C1-30 alkyl optionally substituted with OH or —C(O)OH, and C1-30 heteroalkyl optionally substituted with OH or —C(O)OH, wherein R32 is H or C1-4 alkyl, and R28 is C1-4 alkyl;
when Z1 is N, R20a is absent;
Z2 is C or N;
Z3 is CH2, CHR25, CR25R25, or NR25, O, or S(O)0-2 and R25 is selected from H and alkyl.